Bioasis Technologies Inc. V.BTI

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.

TSXV:BTI - Post by User

Bioasis Technologies Inc. > Midatech at $1.0475

<< Previous

Bullboard Posts

Next >>

Post by Boomskidon Dec 30, 2022 4:03pm

134 Views

Post# 35197665

Midatech at $1.0475

That means that V.BTI's value, as caculated by the terms of the deal, is now about 5.2¢

If U.MTP keeps that up it will be worth it to buy Bioasis instead of MTP.

Hard to imagine 6¢ these days.

jd

<< Previous

Bullboard Posts

Next >>

Silver Range Resources: A hidden gem in the mining industry